May 29, 2021
1 min read

UK approves single-dose J&J Covid vaccine

This is the fourth Covid-19 vaccine to be authorised by the UK’s independent regulator and is the first to be approved for protection against the Covid-19 with a single-dose, reports Asian Lite Newsdesk

The Johnson & Johnson single-dose Covid-19 vaccine has been approved in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) said on Friday.

This is the fourth Covid-19 vaccine to be authorised by the UK’s independent regulator and is the first to be approved for protection against the Covid-19 with a single dose.

“We have undertaken a thorough review of the conditional marketing authorisation application submitted by Janssen (part of Johnson & Johnson), including the information on quality, safety and effectiveness. I am pleased to confirm today that this authorisation has been granted,” MHRA Chief Executive June Raine said in a statement.

single-dose
A man wearing a face mask cycles past the Francis Crick Institute Vaccination Centre in London,UK , Britain, March 18, 2021. (Xinhua/Han Yan/IANS)

“This is encouraging news for the public and the healthcare sector. We now have four safe and effective vaccines approved to help protect us from Covid-19,” Raine added.

The MHRA also obtained independent scientific advice from the Commission on Human Medicines (CHM) and its Covid-19 Expert Working Group.

The MHRA approval authorises the use of the vaccine in people aged 18 and over.

The decision on whether to use the vaccine in pregnant or breast-feeding women should be made in consultation with a healthcare professional after considering the benefits and risks, the statement reads.

The MHRA is thought to have held back from early approval of the vaccine after concerns were raised in the US about a link to extremely rare blood clots, similar to those seen in few people having the Oxford-AstraZeneca jab. Earlier, Health Secretary Matt Hancock said that that almost half, and possibly three-quarters, of all new coronavirus cases in the country are of the B.1.617 variant.

Addressing a press conference at Downing Street, Hancock said: “We always expected cases to rise as we rolled out the roadmap, we must remain vigilant.”

Previous Story

A window of opportunity for India in Afghanistan

Next Story

Jaishankar, Blinken, affirm strong India-US ties

Latest from -Top News

India-EU Trade Talks Resume

The proposed India-EU FTA covers 23 policy areas, or chapters, of which at least two – market access and rules of origin – have yet to be resolved….reports Asian Lite News India

India Launches Relief Ops in Bhutan

The Royal Government of Bhutan has expressed sincere gratitude to the Indian Army…reports Asian Lite News Amid unprecedented floods caused by a low-pressure system over the Bay of Bengal, relentless rainfall has

Piyush Goyal Heads to Doha for Trade Talks

During the visit, both sides are expected to discuss the proposed India–Qatar Free Trade Agreement (FTA)….reports Asian Lite News Union Commerce and Industry Minister Piyush Goyal will travel to Doha, Qatar, on

Jaishankar Hints at Tariff Deal with US

Jaishankar explained that the ongoing trade tensions largely stem from the inability of both sides to reach a common ground on several issues….reports Asian Lite News External Affairs Minister S. Jaishankar on
Go toTop

Don't Miss

Minister apologises for continuing meeting after positive Covid test

The meeting was with three men who had lost their

Congo doubles salaries for beleaguered army  

M23 has seized eastern Congo’s two largest cities in a